Anti–tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study

Authors

Jonas A. Adalsteinsson, Læknadeild Háskóla Íslands
Sonal Muzumdar, UConn Health
Reid Waldman, UConn Health
Chaoran Hu, Connecticut Convergence Institute for Translation in Regenerative Engineering
Rong Wu, Connecticut Convergence Institute for Translation in Regenerative Engineering
Désirée Ratner, NYU Langone Health
Jonathan Ungar, Mount Sinai Department of Dermatology
Jonathan I. Silverberg, The George Washington University School of Medicine and Health Sciences
Gudridur H. Olafsdottir, Icelandic Cancer Registry
Arni Kjalar Kristjansson, Landspitali - The National University Hospital of Iceland
Laufey Tryggvadottir, Læknadeild Háskóla Íslands
Jon Gunnlaugur Jonasson, Læknadeild Háskóla Íslands

Document Type

Journal Article

Publication Date

6-1-2021

Journal

Journal of the American Academy of Dermatology

Volume

84

Issue

6

DOI

10.1016/j.jaad.2020.11.029

APA Citation

Adalsteinsson, J., Muzumdar, S., Waldman, R., Hu, C., Wu, R., Ratner, D., Ungar, J., Silverberg, J., Olafsdottir, G., Kristjansson, A., Tryggvadottir, L., & Jonasson, J. (2021). Anti–tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study. Journal of the American Academy of Dermatology, 84 (6). http://dx.doi.org/10.1016/j.jaad.2020.11.029